{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:36:39Z","timestamp":1768836999233,"version":"3.49.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Tamoxifen (TMX) is one of the most widely used drugs to treat breast cancer (BC). However, acquired drug resistance is still a major obstacle to its application, rendering it crucial to explore the mechanisms of TMX resistance in BC. This aims of this study were to identify the mechanisms of TMX resistance and construct ceRNA regulatory networks in breast cancer.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> GEO2R was used to screen for differentially expressed mRNAs (DEmRNAs) leading to drug resistance in BC cells. MiRTarbase and miRNet were used to predict miRNAs and lncRNAs upstream, and the competing endogenous RNA (ceRNA) regulatory network of BC cell resistance was constructed by starBase. We used the Kaplan\u2013Meier plotter and Gene Expression Profiling Interactive Analysis (GEPIA) to analyze the expression and prognostic differences of genes in the ceRNA network with core axis, and qRT-PCR was used to further verify the above conclusions.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> We found that 21 DEmRNAs were upregulated and 43 DEmRNA downregulated in drug-resistant BC cells. DEmRNAs were noticeably enriched in pathways relevant to cancer. We then constructed a protein-protein interaction (PPI) network based on the STRING database and defined 10 top-ranked hub genes among the upregulated and downregulated DEmRNAs. The 20 DEmRNAs were predicted to obtain 113 upstream miRNAs and 501 lncRNAs. Among them, 7 mRNAs, 22 lncRNAs, and 11 miRNAs were used to structure the ceRNA regulatory network of drug resistance in BC cells. 4 mRNAs, 4 lncRNAs, and 3 miRNAs were detected by GEPIA and the Kaplan\u2013Meier plotter to be significantly associated with BC expression and prognosis. The differential expression of the genes in BC cells was confirmed by qRT-PCR.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The ceRNA regulatory network of TMX-resistant BC was successfully constructed and confirmed. This will provide an important resource for finding therapeutic targets for TMX resistance, where the discovery of candidate conventional mechanisms can aid clinical decision-making. In addition, this resource will help discover the mechanisms behind this type of resistance.<\/jats:p>","DOI":"10.3389\/fcell.2022.1023079","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T07:16:07Z","timestamp":1669360567000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Tamoxifen resistance-related ceRNA network for breast cancer"],"prefix":"10.3389","volume":"10","author":[{"given":"Zipeng","family":"Qiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruifa","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyi","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.7314\/apjcp.2016.17.4.1609","article-title":"HER-2 positive breast cancer - a mini-review","volume":"17","author":"Asif","year":"2016","journal-title":"Asian pac. J. Cancer Prev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.7150\/thno.58410","article-title":"Exosomal lncRNA-H19 promotes osteogenesis and angiogenesis through mediating Angpt1\/Tie2-NO signaling in CBS-heterozygous mice","volume":"11","author":"Behera","year":"2021","journal-title":"Theranostics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1111\/jcmm.13758","article-title":"Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation","volume":"22","author":"Dong","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"963689720929983","DOI":"10.1177\/0963689720929983","article-title":"LncRNA DLX6-AS1 contributes to epithelial-mesenchymal transition and cisplatin resistance in triple-negative breast cancer via modulating mir-199b-5p\/paxillin Axis","volume":"29","author":"Du","year":"2020","journal-title":"Cell Transpl."},{"key":"B6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.4149\/neo_2020_190625N550","article-title":"The SNHG16\/miR-30a axis promotes breast cancer cell proliferation and invasion by regulating RRM2","volume":"67","author":"Du","year":"2020","journal-title":"Neoplasma"},{"key":"B8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1470-2045(21)00758-0","article-title":"Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: A patient-level meta-analysis of 7030 women from four randomised trials","volume":"23","year":"2022","journal-title":"Lancet. Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2100050118","DOI":"10.1073\/pnas.2100050118","article-title":"Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation","volume":"118","author":"Erdelyi","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1158\/1078-0432.CCR-17-2259","article-title":"BQ323636.1, a novel splice variant to NCOR2, as a predictor for tamoxifen-resistant breast cancer","volume":"24","author":"Gong","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cca.2019.12.023","article-title":"Role of SNHG16 in human cancer","volume":"503","author":"Gong","year":"2020","journal-title":"Clin. Chim. Acta."},{"key":"B12","doi-asserted-by":"publisher","first-page":"n6491","DOI":"10.1126\/sciadv.abn6491","article-title":"Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expression","volume":"8","author":"Grima-Reyes","year":"2022","journal-title":"Sci. Adv."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1097\/CAD.0000000000000942","article-title":"Long non-coding RNA X-inactive-specific transcript contributes to cisplatin resistance in gastric cancer by sponging miR-let-7b","volume":"31","author":"Han","year":"2020","journal-title":"Anticancer. Drugs"},{"key":"B14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41416-021-01564-x","article-title":"ESR1 mutations and therapeutic resistance in metastatic breast cancer: Progress and remaining challenges","volume":"126","author":"Herzog","year":"2022","journal-title":"Br. J. Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrclinonc.2013.124","article-title":"Luminal breast cancer: From biology to treatment","volume":"10","author":"Ignatiadis","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"8648","DOI":"10.18632\/oncotarget.3257","article-title":"Basal and therapy-driven hypoxia-inducible factor-1\u03b1 confers resistance to endocrine therapy in estrogen receptor-positive breast cancer","volume":"6","author":"Jia","year":"2015","journal-title":"Oncotarget"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2018.06.003","article-title":"Mixomics analysis of breast cancer: Long non-coding RNA linc01561 acts as ceRNA involved in the progression of breast cancer","volume":"102","author":"Jiang","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1158\/2159-8290.CD-13-0202","article-title":"ceRNA cross-talk in cancer: when ce-bling rivalries go awry","volume":"3","author":"Karreth","year":"2013","journal-title":"Cancer Discov."},{"key":"B19","doi-asserted-by":"publisher","first-page":"9105","DOI":"10.1002\/jcp.27587","article-title":"LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215","volume":"234","author":"Kong","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1186\/s12885-018-4644-7","article-title":"Understanding adjuvant endocrine therapy persistence in breast Cancer survivors","volume":"18","author":"Lambert","year":"2018","journal-title":"BMC Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3946320221105608","DOI":"10.1177\/03946320221105608","article-title":"LINC00680 modulates docetaxel resistance in breast cancer via the miR-320b\/CDKL5 axis","volume":"36","author":"Li","year":"2022","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1002\/jcb.29477","article-title":"SNHG16 as the miRNA let-7b-5p sponge facilitates the G2\/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma","volume":"121","author":"Li","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1172\/JCI94233","article-title":"The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer","volume":"127","author":"Li","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"10449","DOI":"10.1093\/nar\/gkac807","article-title":"A regulatory network comprising let-7 miRNA and SMUG1 is associated with good prognosis in ER+ breast tumours","volume":"50","author":"Lirussi","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.omtn.2021.02.011","article-title":"Comprehensive characterization of a drug-resistance-related ceRNA network across 15 anti-cancer drug categories","volume":"24","author":"Liu","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.3802\/jgo.2018.29.e95","article-title":"LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p","volume":"29","author":"Luan","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.bcp.2012.01.002","article-title":"Role of breast cancer resistance protein (BCRP\/ABCG2) in cancer drug resistance","volume":"83","author":"Natarajan","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41392-020-0129-7","article-title":"Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+\u03b3\u03b41 Treg cells","volume":"5","author":"Ni","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41422-020-00397-2","article-title":"Oncogenic AURKA-enhanced N(6)-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cells","volume":"31","author":"Peng","year":"2021","journal-title":"Cell Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12943-017-0727-3","article-title":"Linc-RoR promotes MAPK\/ERK signaling and confers estrogen-independent growth of breast cancer","volume":"16","author":"Peng","year":"2017","journal-title":"Mol. Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jmedgenet-2015-103334","article-title":"ceRNA in cancer: possible functions and clinical implications","volume":"52","author":"Qi","year":"2015","journal-title":"J. Med. Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s12935-020-01563-7","article-title":"Inhibition of let-7b-5p contributes to an anti-tumorigenic macrophage phenotype through the SOCS1\/STAT pathway in prostate cancer","volume":"20","author":"Rong","year":"2020","journal-title":"Cancer Cell Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: The rosetta stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1016\/j.ymthe.2021.11.002","article-title":"circRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p\/FOXO3a Axis in breast cancer","volume":"29","author":"Sang","year":"2021","journal-title":"Mol. Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"Ca. Cancer J. Clin."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1158\/1535-7163.MCT-19-1004","article-title":"ARX788, a site-specific anti-HER2 antibody-drug conjugate, demonstrates potent and selective activity in HER2-low and T-DM1-resistant breast and gastric cancers","volume":"19","author":"Skidmore","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jss.2018.11.030","article-title":"miR-145-5p suppresses breast cancer progression by inhibiting SOX2","volume":"236","author":"Tang","year":"2019","journal-title":"J. Surg. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","article-title":"Endogenous microRNA sponges: Evidence and controversy","volume":"17","author":"Thomson","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1038\/onc.2014.351","article-title":"A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells","volume":"34","author":"Thrane","year":"2015","journal-title":"Oncogene"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1158\/2159-8290.CD-19-1390","article-title":"The genomic landscape of intrinsic and acquired resistance to cyclin-dependent kinase 4\/6 inhibitors in patients with hormone receptor-positive metastatic breast cancer","volume":"10","author":"Wander","year":"2020","journal-title":"Cancer Discov."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.7150\/thno.45302","article-title":"Estrogen-induced circRNA, circPGR, functions as a ceRNA to promote estrogen receptor-positive breast cancer cell growth by regulating cell cycle-related genes","volume":"11","author":"Wang","year":"","journal-title":"Theranostics"},{"key":"B42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-021-01332-8","article-title":"CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K\/AKT pathway","volume":"20","author":"Wang","year":"","journal-title":"Mol. Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1182\/blood.2019004090","article-title":"Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL","volume":"136","author":"Watanabe","year":"2020","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2147\/OTT.S186923","article-title":"LncRNA SNHG16 drives proliferation and invasion of papillary thyroid cancer through modulation of miR-497","volume":"12","author":"Wen","year":"2019","journal-title":"Onco. Targets. Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1038\/s41388-021-01969-1","article-title":"Nuclear aurora-A kinase-induced hypoxia signaling drives early dissemination and metastasis in breast cancer: Implications for detection of metastatic tumors","volume":"40","author":"Whately","year":"2021","journal-title":"Oncogene"},{"key":"B46","doi-asserted-by":"publisher","first-page":"628573","DOI":"10.3389\/fcell.2021.628573","article-title":"Extracellular vesicles carry lncRNA SNHG16 to promote metastasis of breast cancer cells via the miR-892b\/ppapdc1a Axis","volume":"9","author":"Xia","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"705697","DOI":"10.3389\/fcell.2021.705697","article-title":"LncRNA NEAT1 promotes gastric cancer progression through miR-17-5p\/tgf\u00dfr2 Axis up-regulated angiogenesis","volume":"9","author":"Xu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12935-020-01291-y","article-title":"SNHG16 promotes tumorigenesis and cisplatin resistance by regulating miR-338-3p\/PLK4 pathway in neuroblastoma cells","volume":"20","author":"Xu","year":"2020","journal-title":"Cancer Cell Int."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/tox.22938","article-title":"Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells","volume":"35","author":"Yan","year":"2020","journal-title":"Environ. Toxicol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"7216","DOI":"10.1038\/s41388-019-0904-5","article-title":"Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069\/miR-129-5p\/Twist1 axis","volume":"38","author":"Yao","year":"2019","journal-title":"Oncogene"},{"key":"B51","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2147\/OTT.S175176","article-title":"Long noncoding RNA SNHG16 induces sorafenib resistance in hepatocellular carcinoma cells through sponging miR-140-5p","volume":"12","author":"Ye","year":"2019","journal-title":"Onco. Targets. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.trecan.2017.09.001","article-title":"Breast cancer: Multiple subtypes within a tumor?","volume":"3","author":"Yeo","year":"2017","journal-title":"Trends Cancer"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3389\/fonc.2019.01072","article-title":"Asparagine synthetase and filamin A have different roles in ovarian cancer","volume":"9","author":"Zeng","year":"2019","journal-title":"Front. Oncol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1111\/cas.14634","article-title":"A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration","volume":"111","author":"Zhang","year":"2020","journal-title":"Cancer Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.2119\/molmed.2010.00225","article-title":"let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor alpha signaling in breast cancer","volume":"17","author":"Zhao","year":"2011","journal-title":"Mol. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1186\/s12885-019-5983-8","article-title":"Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue","volume":"19","author":"Zhou","year":"2019","journal-title":"BMC Cancer"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.1023079\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T07:16:09Z","timestamp":1669360569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.1023079\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,25]]},"references-count":54,"alternative-id":["10.3389\/fcell.2022.1023079"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2022.1023079","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,25]]},"article-number":"1023079"}}